First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studies.
about
Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic AgentsQuantitative perfusion- and diffusion-weighted magnetic resonance imaging of gastrointestinal cancers treated with multikinase inhibitors: a pilot study.Whole exome sequencing of a single osteosarcoma case--integrative analysis with whole transcriptome RNA-seq data.3-(Benzo[d][1,3]dioxol-5-ylamino)-N-(4-fluorophenyl)thiophene-2-carboxamide overcomes cancer chemoresistance via inhibition of angiogenesis and P-glycoprotein efflux pump activity.Clinical development landscape in GIST: from novel agents that target accessory pathways to revisiting non-targeted therapies.Contrast agents in dynamic contrast-enhanced magnetic resonance imaging.New targets and therapies for gastrointestinal stromal tumors.Design, synthesis, and screening of ortho-amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2Inhibitors
P2860
Q26740567-15FA7155-092D-4661-8D60-EC183CF7232EQ34229404-87D89F10-DBE1-44FE-B258-DA4A25DACBB4Q35511058-DAD9A8BB-8477-4B2A-BE3C-3D8C536E47BBQ38901475-7ADACD5E-1C88-4651-951D-B5D7646F911BQ38925022-216E257E-0F4F-421B-BA19-9FA586245D44Q39246340-F1B6F759-6B7F-46DE-846D-A4F3427B1D68Q47432725-6D77A203-354F-4D04-BEB4-278CC4051DEEQ58759036-073E61A6-EF04-4187-928C-413631245E54
P2860
First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
First-in-human phase I trial o ...... al proof-of-mechanism studies.
@en
First-in-human phase I trial o ...... al proof-of-mechanism studies.
@nl
type
label
First-in-human phase I trial o ...... al proof-of-mechanism studies.
@en
First-in-human phase I trial o ...... al proof-of-mechanism studies.
@nl
prefLabel
First-in-human phase I trial o ...... al proof-of-mechanism studies.
@en
First-in-human phase I trial o ...... al proof-of-mechanism studies.
@nl
P2093
P2860
P1476
First-in-human phase I trial o ...... nal proof-of-mechanism studies
@en
P2093
Andrew Stephens
D Ross Camidge
George Demetri
Hendrik-Tobias Arkenau
James Spicer
Jennifer L Spratlin
Katie Brock
Michelle Scurr
Nandita M Desouza
P2860
P304
P356
10.1158/1078-0432.CCR-12-2258
P407
P50
P577
2013-02-12T00:00:00Z